Filter posts

Patent Parameters

Supreme Court Finds Naturally Occurring DNA to Be Patent Ineligible Last summer, the Supreme Court …

US Public Organizations Leading Genomic Research, with Europe and Asia Catching Up

Since before the mapping of the human genome just over a decade ago, we have …

Supreme Court Enunciates New Indefiniteness Standard

The Supreme Court has once again reversed a decision by the Federal Circuit, in this …

Patent Reform Legislation Off The Table For Now

If the mainstream media is to be believed, the patent system is broken.  This notion …

Supreme Court Decision on Web Content Delivery to Impact Biotech Patents

Earlier this month, in Limelight Networks, Inc. v. Akamai Technologies, Inc., the Supreme Court issued …

IP at the 2014 BIO International Convention

Securing and maintaining intellectual property protection for the next generation of biotech innovation faces new …

Nautilus v. Biosig, Baxter v. Fresenius and Limelight v. Akamai

BIO weighed in on three Supreme Court cases in the last few months whose outcome …

Corporate-Sponsored University Research Valuable for Further Innovation

New research published in Nature, Technology Transfer: Industry-funded academic inventions boost innovation, provides data undermining …

Gene Patent Questions Remain: USPTO Issues Examiner Guidelines

The new Patent Office guidance, issued March 4, extends the Supreme Court’s legal logic into …

Special 301: BIO Highlights Challenges in India

BIO recently testified before the U.S. government on the intellectual property challenges our members face …